A first for venous in-stent thrombosis.
RevCore is the first mechanical thrombectomy device developed to treat acute to chronic in-stent thrombosis.
The nitinol element in the RevCore Thrombectomy Catheter provides seamless interaction with implanted venous stents for the treatment of in-stent thrombosis.
A) Right size, right time: Expandable element diameter up to 20 mm
B) Complete control: Accurate and immediate torque response in targeted segment
REVIT Study
The first prospective registry of RevCore for the treatment of in-stent thrombosis.
Connect with an expert
Engage with us on social media to find information about upcoming MedEd events, including webinars, and to be among the first to receive news on technology enhancements, new clinical data and more.
Indications for Use
The RevCore thrombectomy catheter is indicated for (1) the non-surgical removal of thrombi and emboli from blood vessels and (2) injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The RevCore thrombectomy catheter is intended for use in the peripheral vasculature.
Review complete Instructions for Use, Indications for Use, Warnings, Precautions, Possible Adverse Effects and Contraindications prior to use of the product.
Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.
PRO-4502-USA-EN-v1